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Improving a Multi-disciplinary Tumor Board
Jason Lachance, MD, MSc, Tracy Watts, RN, Cyndi O’Brien, RN
MMP Women’s Health- Gynecologic Oncology
Problem/Impact Statement

5 Why’s

Countermeasures
By When & Status*

Who

Deliverable

Problem:

Plan

The project aims to address the coordination of care and services
and referrals associated with the comprehensive care of women with
gynecologic cancers. It does not aim to address issues of pathologic
diagnosis or clinical cancer outcomes.

Department of
OBGYN

End Q2

MMC Cancer
Program
Clinical
Creation of list, shared with Pathology
Navigator
(Gyn Oncology)

End Q3

Multidisciplinary
Discussion and review of indications
oncologists

End Q4

Molecular
Tumor Board

Why?
Patients receive inconsistent and conflicting
messaging from clinicians not present at Tumor
Board (non-MMC oncologists, PCPs, etc)

Scope

End Q1

Do

GYN Oncology Tumor Board has been a loosely constructed and
somewhat informal process that would benefit from more rigor and
documentation for better communication of results, better patient
care, adherence to national guidelines, and cancer center certification.

Women with gynecologic cancer are not uniformly
receiving standard of care therapy.

Why?

List generation through OBGYN
residents and APPs

Primary treating oncologist misses Tumor Board
discussion (vacation, clinical conflicts)

Why?

Maine Cancer Genomic Initiative
(Jackson Labs)
Outcomes

Clinical support staff in the practice are not aware of
consensus recommendations for appropriate
referrals.
Why?

The goal of the project is to demonstrably record the recommended
interventions that arise out of mutli-disciplinary tumor board
discussions.

Current State

Study

Goal/Objective

Referrals for adjuvant therapy (genetics, radiation,
chemotherapy, non-MMC) are not being placed.
Why?

Next Steps

Act

No documentation of Tumor Board
recommendations or discussion of options

Currently (August 2019) there is no record of Tumor Board
discussions. As a result, there is inconsistent compliance with
recommended care, even when recommended or discussed.

Solution:

Discussions and recommendations from Tumor
Board should be documented and circulated

• 310 patients were reviewed from 1/1/2020
• All patients have a documented plan of recommendations
(adjuvant therapy, referrals)
• COVID challenges/opportunities
o Virtual Tumor Board has increased attendance
• Improved Screening for Clinical Trials
• Addition of Molecular Tumor Board (MCGI/Jackson Lab)

• Better documentation in the EHR
o Current state is Excel spreadsheet on shared drive
• Better quality assurance on referrals
o Are they occurring? What are results?

